Tolerability of 2.5% Lidocaine/Prilocaine Hydrogel in Children Undergoing Cryotherapy for Molluscum Contagiosum
| Autor: | Ronilson Agnaldo Moreno, André Alves Moraes Gobbato, Cintia Aparecida Rodrigues Santiago Gobbato, Gilberto De Nucci, Thiago Gagliano-Jucá, Tainah Babadópulos |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Male
medicine.medical_specialty Molluscum Contagiosum Lidocaine/prilocaine Lidocaine medicine.medical_treatment Pain Cryotherapy Dermatology 030226 pharmacology & pharmacy Hydrogel Polyethylene Glycol Dimethacrylate Prilocaine 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Topical anesthesia Humans Medicine Anesthetics Local Child Pain Measurement Molluscum contagiosum business.industry Patch test Drug Tolerance medicine.disease Drug Combinations Treatment Outcome Tolerability Child Preschool Anesthesia Pediatrics Perinatology and Child Health Female business medicine.drug |
| Zdroj: | Pediatric Dermatology. 33:e214-e215 |
| ISSN: | 0736-8046 |
| Popis: | The tolerability of a 2.5% lidocaine/prilocaine hydrogel (Nanorap, Biolab Indústria Farmacêutica Ltd., Sao Paulo, Brazil) was evaluated in 20 children ages 2 to 11 years undergoing cryotherapy for molluscum contagiosum (MC). The product was well tolerated, with only two children presenting with eczema at the application site. These adverse reactions were considered unlikely to be related to the test product, because a patch test was negative in one of the individuals and the other event occurred in only one of the two treated areas. Nanorap is an efficacious and well-tolerated option for topical anesthesia in children undergoing cryotherapy for MC. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text